Cardiff Oncology Inc. (CRDF) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2021-11-19
4:02 pm
Purchase		2021-11-1813GCardiff Oncology, Inc.
CRDF		PFIZER INC
PFE		2,411,575
5.750%		2,411,575increase
(New Position)		Filing
History
2021-02-16
3:30 pm
Purchase		2021-12-3113GCardiff Oncology, Inc.
CRDF		CAXTON CORP3,098,447
8.800%		1,140,204increase
(+58.23%)		Filing
History
2021-02-16
06:18 am
Purchase		2020-12-3113GCardiff Oncology, Inc.
CRDF		Corriente Advisors LLC2,000,000
5.660%		2,000,000increase
(New Position)		Filing
History
2021-02-12
5:20 pm
Purchase		2020-12-3113GCardiff Oncology, Inc.
CRDF		Opaleye Management Inc.1,662,500
4.710%		414,500increase
(+33.21%)		Filing
History
2021-02-12
3:06 pm
Purchase		2020-12-3113GCardiff Oncology, Inc.
CRDF		JANUS HENDERSON GROUP PLC
JHG		2,137,671
6.100%		2,137,671increase
(New Position)		Filing
History
2021-02-11
12:55 pm
Purchase		2020-12-3113GCardiff Oncology, Inc.
CRDF		STATE STREET CORP
STT		2,548,772
7.220%		2,548,772increase
(New Position)		Filing
History
2021-02-10
4:46 pm
Sale		2021-01-3113GCardiff Oncology, Inc.
CRDF		RA Capital Management, L.P.0
0.000%		-3,290,000decrease
(Position Closed)		Filing
History
2021-02-01
6:10 pm
Purchase		2021-01-2913GCardiff Oncology, Inc.
CRDF		Avidity Partners Management LP2,153,600
6.100%		2,153,600increase
(New Position)		Filing
History
Goto Prev, 0, 1